Company
Amlogenyx
| Industry | subsidiary of Ultragenyx Pharmaceutical, Inc. (NASDAQ: RARE) which is researching and developing novel gene therapies for Alzheimer’s disease and other amyloid diseases |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Amlogenyx | Seed Funding | 2024-08-05 |